Shin Nippon Biomedical Laboratories, Ltd. (OTCMKTS:SBLOF – Get Free Report) saw a significant decline in short interest during the month of August. As of August 31st, there was short interest totaling 25,129 shares, a decline of 44.9% from the August 15th total of 45,628 shares. Based on an average daily volume of 0 shares, the short-interest ratio is presently ∞ days.
Shin Nippon Biomedical Laboratories Stock Performance
OTCMKTS:SBLOF opened at $7.00 on Wednesday. The company’s 50-day simple moving average is $7.00 and its 200-day simple moving average is $8.21. Shin Nippon Biomedical Laboratories has a fifty-two week low of $7.00 and a fifty-two week high of $9.16.
About Shin Nippon Biomedical Laboratories
Shin Nippon Biomedical Laboratories, Ltd. (OTCMKTS: SBLOF) is a Japan‐based contract research organization specializing in nonclinical safety assessment for the pharmaceutical, biotechnology and agrochemical industries. Established in 1978 and headquartered in Kagoshima, the company provides a range of preclinical testing services designed to support drug development from early discovery through regulatory submission. SBLOF is known for its adherence to Good Laboratory Practice (GLP) standards and its focus on high‐quality data generation and compliance.
The company’s core services include toxicology studies, pharmacokinetics and bioanalysis, safety pharmacology, pathology and genetic toxicology.
See Also
- Five stocks we like better than Shin Nippon Biomedical Laboratories
- The Ultimate Cyber Shield: CrowdStrike Rises Past $235
- Palantir Just Told Wall Street Where AI Infrastructure Is Headed
- Homebuilders Are Down for the Year, Is Wall Street in Denial?
- Turning Trash to Cash: A $129M Bet on Waste
Receive News & Ratings for Shin Nippon Biomedical Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shin Nippon Biomedical Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
